Vorasidenib目前正在FDA的优先审查中,用于治疗一种名为idh突变弥漫性胶质瘤的脑肿瘤,目标作用日期为2...查看全文
美股滚雪球05-23 09:51
$Cytokinetics(CYTK)$ 和$Royalty Pharma(RPRX)$ 宣布了高达5.75亿美元的合作,其中包括2.5亿美元的预付款,以支持Cytokinetics药物aficamten的商业化和其管道的推进。
根据该协议,Cytokinetics将获得5000万美元用于商业上市,并在该药获得FDA批准用于治疗阻塞性肥厚性心肌病(oHCM)的12个月内...查看全文
Royalty Pharma(RPRX)06-11 04:15
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001802768-24-000031 Size: 5 KB 网页链接查看全文
Royalty Pharma(RPRX)06-11 04:15
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001802768-24-000029 Size: 5 KB 网页链接查看全文
Royalty Pharma(RPRX)06-11 04:25
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001802768-24-000035 Size: 5 KB 网页链接查看全文
Royalty Pharma(RPRX)06-20 20:05
$Royalty Pharma(RPRX)$ 8-K Current report, item 8.01 Accession Number: 0001193125-24-164004 Act: 34 Size: 158 KB 网页链接查看全文
Royalty Pharma(RPRX)04-26 04:15
$Royalty Pharma(RPRX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001140361-24-022035 Act: 34 Size: 8 MB 网页链接查看全文
Royalty Pharma(RPRX)04-26 04:15
$Royalty Pharma(RPRX)$ DEF 14A Other definitive proxy statements Accession Number: 0001140361-24-022029 Act: 34 Size: 13 MB 网页链接查看全文
Royalty Pharma(RPRX)06-05 05:05
$Royalty Pharma(RPRX)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001193125-24-154347 Act: 34 Size: 467 KB 网页链接查看全文
Royalty Pharma(RPRX)06-11 04:25
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001802768-24-000033 Size: 5 KB 网页链接查看全文
shimla12016-04-13 22:00
$Repros Therapeutics(RPRX)$ 涨翻了哈哈哈,昨天盘后最多的时候涨了百分之八十,全卖了,之前说跌倒到谷底要大反弹,还有人还不信查看全文
追魂十三剑2014-10-22 04:40
$Repros Therapeutics(RPRX)$ released positive datas now 网页链接 short squeeze tomorrow..查看全文
来源:格隆汇 格隆汇6月14日丨Royalty Pharma(RPRX.US)盘前涨11.89%,报36.24美元。最新披露数据显示,高管Legorreta Pablo G.于6月12日、13日以每股平均价32.8872美元增持9万股普通股股份,价值约为295.98万美... 网页链接
三季度13F文件显示,伯克希尔哈撒韦第三季度增持雪佛龙(CVX.N)(增持约558万股),建仓生物技术公司Royalty Pharma(RPRX.O)超1314万股、清仓默沙东(MRK.N)约916万股,并减持Visa(V.N)和美国合众银行(USB.N)等金融股。 前四大重仓... 网页链接
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001802768-24-000040 Size: 4 KB 网页链接
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001802768-24-000042 Size: 5 KB 网页链接
$Royalty Pharma(RPRX)$ 8-K Current report, item 8.01 Accession Number: 0001193125-24-164004 Act: 34 Size: 158 KB 网页链接
$Royalty Pharma(RPRX)$ 8-K Current report, items 1.01, 2.03, and 9.01 Accession Number: 0001193125-24-158417 Act: 34 Size: 468 KB 网页链接
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001802768-24-000033 Size: 5 KB 网页链接
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001802768-24-000035 Size: 5 KB 网页链接
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001802768-24-000038 Size: 5 KB 网页链接
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001802768-24-000025 Size: 5 KB 网页链接
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001802768-24-000027 Size: 4 KB 网页链接
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001802768-24-000029 Size: 5 KB 网页链接